Adherence to Advisory Committee on Immunization Practices in diabetes mellitus patients in Saudi Arabia: A multicenter retrospective study

Table 1 Centers for Disease Control and Prevention/Advisory Committee on Immunization Practices vaccine recommendations for diabetic patients

Vaccine	Recommendation
IIV (IIV4 or RIV4 or LAIV)	Received every year
Tdap and Td vaccine	Tdap is received once followed by a Td booster dose every ten years
PCV (PCV151 or PCV20)	Given once to previously unimmunized diabetic adults who are 19-64 years old or unimmunized adults ≥ 65
Hepatitis B vaccine	All previously unimmunized adults 19-59 years old. Diabetic adults ≥ 60 years old
HPV vaccine	Given in two or three doses as early as 9 years old and up to 26 years old and in some cases up to 47 years old
Herpes zoster vaccine	All adults ≥ 50
Chickenpox (varicella) vaccine	Two doses with 4-8 wk interval to all previously unimmunized ≥ 13 adolescents and adult
MMR vaccine	One or two doses with 28 d interval for unimmunized adults

¹Pneumococcal vaccine 15 is followed by a 23-valent pneumococcal polysaccharide vaccine booster at least 1 year later.

IIV: Influenza vaccine; RIV: Recombinant influenza vaccine; LAIV: Live-attenuated influenza virus; Tdap: Tetanus, diphtheria, and pertussis; Td: Tetanus and diphtheria; PCV: Pneumococcal vaccine; HPV: Human papillomavirus; MMR: Measles, mumps, and rubella.